systhiperСистемные гипертензииSystemic Hypertension2075-082X2542-2189LLC «ИнтерМедсервис»systhiper-159Research ArticleСТАТЬИARTICLESУправляемое лечение больных с сахарным диабетом типа 2: результаты исследования ADVANCEКарповЮ. А.noemail@neicon.ruФГУ РКНПК Федерального агентства по высокотехнологичной медицинской помощи, МоскваRussian Federation20082312202254712Copyright © Карпов Ю.А., 20222022Карпов Ю.А.Карпов Ю.А.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.syst-hypertension.ru/jour/article/view/159ReferencesAdler A, Stratton IM, Neil H et al. Assoсiation of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000; 321: 412-9.Adler A, Stratton IM, Neil H et al. Assoсiation of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000; 321: 412-9.The Task Force for the management of arterial hypertension of the European Society of Hypertension and of the European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension. J Hypertens 2007; 25: 1105-87.The Task Force for the management of arterial hypertension of the European Society of Hypertension and of the European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension. J Hypertens 2007; 25: 1105-87.The Task Forсе on Diabetes and Cardiovascular Disease of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes, and cardiovascular disease: executive summary. Eur Heart J 2007; 28: 88-136.The Task Forсе on Diabetes and Cardiovascular Disease of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes, and cardiovascular disease: executive summary. Eur Heart J 2007; 28: 88-136.Stratton IM, Adler AL, Neil HA et al. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-12.Stratton IM, Adler AL, Neil HA et al. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-12.Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-13.Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-13.The АDVANCE Collaborative Group: Rationale and design of the АDVANCE Study: a randomised trial of blood pressure lowering and intensive glucose control in high risk individuals with Type 2 diabetes mellitus. J Hypertens 2001; 19: 21-28.The АDVANCE Collaborative Group: Rationale and design of the АDVANCE Study: a randomised trial of blood pressure lowering and intensive glucose control in high risk individuals with Type 2 diabetes mellitus. J Hypertens 2001; 19: 21-28.АDVANCE Collaborative Group/ADVANCE - Action in diabetes and vascular disease: patient recruitment and characteristics of the study population at baseline. Diabet. Med. 2005; 1-7.АDVANCE Collaborative Group/ADVANCE - Action in diabetes and vascular disease: patient recruitment and characteristics of the study population at baseline. Diabet. Med. 2005; 1-7.ADVANCE Collaborative Group. Effects of fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007; 370: 828-40.ADVANCE Collaborative Group. Effects of fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007; 370: 828-40.The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-72.The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-72.ACCORD.ACCORD.Cefalu WT, Watson K. Intensive glycemic control and cardiovascular disease. Observations from the ACCORD study. Diabetes 2008; 57: 1163-5.Cefalu WT, Watson K. Intensive glycemic control and cardiovascular disease. Observations from the ACCORD study. Diabetes 2008; 57: 1163-5.Goede P, Lund-Andersen H, Parving HH et al. Effect of multifactorial intervention on mortality in tipe 2 diabetes. N Engl J Med 2008; 358: 580-9.Goede P, Lund-Andersen H, Parving HH et al. Effect of multifactorial intervention on mortality in tipe 2 diabetes. N Engl J Med 2008; 358: 580-9.Holman RR, Paul SJ, Bethel MA et al. Ten-year follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 2008; 359 (15); 1577-89.Holman RR, Paul SJ, Bethel MA et al. Ten-year follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 2008; 359 (15); 1577-89.Chalmers J. ADVANCE: new results. EASD 2008 Meeting, September 8. Oral presentation.Chalmers J. ADVANCE: new results. EASD 2008 Meeting, September 8. Oral presentation.
The authors declare that there are no conflicts of interest present.